INVESTORS

Investor Documents

Every investor document in one place: the corporate presentation, financial reports, shareholder meeting materials, governance policies and historical CSE filings.

CORPORATE PRESENTATION

RIWI Investor Presentation

Our current corporate presentation for investors (PDF).

FINANCIAL REPORTS

Financial Statements And MD&A

2026

2 filings
PeriodFinancial StatementsMD&A
Q2Interim
FSMD&A
Q1Interim
FSMD&A

2025

4 filings
PeriodFinancial StatementsMD&A
AnnualAudited
FSMD&A
Q3Interim
FSMD&A
Q2Interim
FSMD&A
Q1Interim
FSMD&A

2024

4 filings
PeriodFinancial StatementsMD&A
AnnualAudited
FSMD&A
Q3Interim
FSMD&A
Q2Interim
FSMD&A
Q1Interim
FSMD&A

2023

4 filings
PeriodFinancial StatementsMD&A
AnnualAudited
FSMD&A
Q3Interim
FSMD&A
Q2Interim
FSMD&A
Q1Interim
FSMD&A

2022

4 filings
PeriodFinancial StatementsMD&A
AnnualAudited
FSMD&A
Q3Interim
FSMD&A
Q2Interim
FSMD&A
Q1Interim
FSMD&A

2021

4 filings
PeriodFinancial StatementsMD&A
AnnualAudited
FSMD&A
Q3Interim
FSMD&A
Q2Interim
FSMD&A
Q1Interim
FSMD&A

2020

4 filings
PeriodFinancial StatementsMD&A
AnnualAudited
FSMD&A
Q3Interim
FSMD&A
Q2Interim
FSMD&A
Q1Interim
FSMD&A

2019

4 filings
PeriodFinancial StatementsMD&A
AnnualAudited
FSMD&A
Q3Interim
FSMD&A
Q2Interim
FSMD&A
Q1Interim
FSMD&A

2018

4 filings
PeriodFinancial StatementsMD&A
AnnualAudited
FSMD&A
Q3Interim
FSMD&A
Q2Interim
FSMD&A
Q1Interim
FSMD&A

2017

4 filings
PeriodFinancial StatementsMD&A
AnnualAudited
FSMD&A
Q3Interim
FSMD&A
Q2Interim
FSMD&A
Q1Interim
FSMD&A

2016

4 filings
PeriodFinancial StatementsMD&A
AnnualAudited
FSMD&A
Q3Interim
FSMD&A
Q2Interim
FSMD&A
Q1Interim
FSMD&A

2015

3 filings
PeriodFinancial StatementsMD&A
AnnualAudited
FSMD&A
Q3Interim
FSMD&A
Q2Interim
FSMD&A

SHAREHOLDER MEETINGS

Annual general meetings

CEO ANNUAL LETTER 2026

Letter to Shareholders

Greg Wong, CEO, on the past year and the year ahead: strategy, milestones, and what RIWI is building next.

Read the 2026 Letter

2017

Annual General Meeting

2016

Annual General Meeting

GOVERNANCE

Policies and committee charters

All policies are reviewed annually by the Board of Directors.

  • Code of Business Conduct and Ethics

    RIWI's standards for ethical business conduct, applicable to all directors, officers, and employees.

    Approved December 15, 2015

    Download PDF
  • Anti-Corruption Policy

    Policy prohibiting bribery and corruption in any form, in compliance with Canadian and applicable foreign anti-corruption laws.

    Approved December 15, 2015

    Download PDF
  • Audit Committee Charter

    Governs the composition and responsibilities of the Audit Committee, including financial reporting oversight and external auditor relations.

    Download PDF
  • Human Resources, Compensation & Nominating Committee Charter

    Governs the HR, Compensation & Nominating Committee. Approved by the Board on August 23, 2023.

    Approved August 23, 2023

    Download PDF

HISTORICAL DISCLOSURE

CSE Form 7 Monthly Progress Reports (2017–2020)

Filed during RIWI's prior listing on the Canadian Securities Exchange before graduating to TSX Venture. Retained for completeness of public filing history.

View 34 historical CSE Form 7 monthly reports (20172020)

These reports were filed under CSE Policy 6 during RIWI’s listing on the Canadian Securities Exchange prior to graduating to the TSX Venture Exchange. They are retained for historical disclosure access.

QUESTIONS?

Talk to Investor Relations.

Email investors@riwi.com for additional financial information or analyst inquiries.

The finale
R / 01
Forward-Looking Statements

This site contains forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking statements are based on assumptions and reflect management's current expectations as of the date the statements are made; actual results may differ materially from those expressed or implied. RIWI Corp undertakes no obligation to update forward-looking statements except as required by law. Investors are urged to review the company's continuous-disclosure filings on SEDAR+ for a complete description of risk factors.